Accumulating evidence demonstrates that HIF-2α, rather than HIF-1α, is the primary oncogenic driver in RCC and can act as a nuclear tumor promoter.36,37 However, unlike HIF-1α, HIF-2α plays a unique role in the tumor cytoplasm. Here, EPAS1 is linked to renal cell carcinoma.